Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Prevention and treatment of hepatic venocclusive disease after high-dose cytoreductive therapy.

Prevention and treatment of hepatic venocclusive disease after high-dose cytoreductive therapy. Leuk Lymphoma. 1998 Oct; 31(3-4):267-77.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.